通过USP11/Nrf2正反循环,通过抑制线粒体亡,促进结直肠癌的进展
Yuanyuan Lu1,2,3, Wanhui Wei4,5, Mengting Li1,2
1Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Cell death & disease
|December 1, 2024
概括
双化酶USP11通过稳定Nrf2促进结直肠癌,创建一个反循环,抑制细胞亡并维持氧化还原稳定.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 异常的抗氧化能力与癌症恶性病变有关,使氧化应激成为治疗目标.
- 核因子红色素2相关因子2 (Nrf2) 调节抗氧化酶,但其二氧化化机制尚未完全理解.
研究的目的:
- 研究USP11在结直肠癌 (CRC) 中的作用及其对Nrf2.2的调节.
- 阐明USP11/Nrf2反循环在CRC进展中的机制.
主要方法:
- 在CRC组织中USP11表达的分析.
- 研究USP11对Nrf2稳定性和降解的影响.
- 对USP11促进体有约束性的Nrf2的识别.
- 评估活性氧物种 (ROS) 水平和线粒体亡.
主要成果:
- USP11在CRC中过度表达,并通过抑制线粒体亡而起瘤基因的作用.
- USP11对Nrf2进行二氧化和稳定,防止其蛋白质体降解.
- Nrf2与USP11促进体结合,增强其转录,形成一个积极的反循环.
- 这种USP11/Nrf2循环维持了氧化还原平衡,并促进了CRC的进展.
结论:
- USP11/Nrf2正反循环通过Nrf2/ARE通路抑制线粒体亡,促进结直肠癌.
- 在CRC中USP11过度表达与预后不佳有关.
- 针对USP11可能为结直肠癌提供治疗策略.
更多相关视频
04:20Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
876
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
相关概念视频
Electron Transport Chain: Complex I and II
11.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
